| Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
|---|
| PPM1D protein | 30 | 0 | 0 | 30 |
| Bone morphogenetic protein receptor type-1B | 0 | 0 | 9 | 9 |
| Membrane-associated progesterone receptor component 1 | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase PLK4 | 0 | 1 | 9 | 10 |
| ATP-dependent RNA helicase DDX3X | 0 | 0 | 7 | 7 |
| Pyridoxal kinase | 0 | 0 | 7 | 7 |
| Citron Rho-interacting kinase | 0 | 1 | 9 | 10 |
| Serine/threonine-protein kinase Chk1 | 0 | 0 | 10 | 10 |
| Aurora kinase A | 0 | 3 | 9 | 12 |
| Cyclin-G-associated kinase | 0 | 1 | 9 | 10 |
| Ephrin type-B receptor 6 | 0 | 0 | 9 | 9 |
| Peroxisomal acyl-coenzyme A oxidase 3 | 0 | 0 | 7 | 7 |
| Receptor-interacting serine/threonine-protein kinase 2 | 0 | 5 | 9 | 14 |
| Mitotic checkpoint serine/threonine-protein kinase BUB1 | 0 | 0 | 6 | 6 |
| Dynamin-like 120 kDa protein, mitochondrial | 0 | 0 | 7 | 7 |
| Eukaryotic translation initiation factor 5B | 0 | 0 | 5 | 5 |
| Rho-associated protein kinase 2 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase ULK1 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase/endoribonuclease IRE1 | 0 | 0 | 9 | 9 |
| Ribosomal protein S6 kinase alpha-5 | 0 | 0 | 9 | 9 |
| U5 small nuclear ribonucleoprotein 200 kDa helicase | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-4 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase 16 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase 10 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase D3 | 0 | 2 | 9 | 11 |
| Structural maintenance of chromosomes protein 2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 6 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase kinase 4 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase LATS1 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase PAK 4 | 0 | 0 | 9 | 9 |
| Tyrosine-protein kinase ABL1 | 0 | 12 | 11 | 25 |
| Epidermal growth factor receptor | 0 | 10 | 9 | 19 |
| Interferon beta | 37 | 0 | 0 | 37 |
| High affinity nerve growth factor receptor | 0 | 1 | 9 | 10 |
| Guanine nucleotide-binding protein G(i) subunit alpha-2 | 0 | 0 | 5 | 5 |
| ADP/ATP translocase 2 | 0 | 0 | 7 | 7 |
| Protein kinase C beta type | 0 | 2 | 7 | 9 |
| Insulin receptor | 0 | 4 | 9 | 13 |
| Tyrosine-protein kinase Lck | 0 | 10 | 9 | 19 |
| Tyrosine-protein kinase Fyn | 0 | 7 | 9 | 16 |
| Cyclin-dependent kinase 1 | 0 | 2 | 7 | 9 |
| Glycogen phosphorylase, liver form | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Fes/Fps | 0 | 0 | 9 | 9 |
| Adenine phosphoribosyltransferase | 0 | 0 | 5 | 5 |
| Tyrosine-protein kinase Yes | 0 | 1 | 9 | 10 |
| Tyrosine-protein kinase Lyn | 0 | 2 | 9 | 11 |
| Proto-oncogene tyrosine-protein kinase receptor Ret | 0 | 4 | 9 | 13 |
| Insulin-like growth factor 1 receptor | 0 | 2 | 9 | 11 |
| Signal recognition particle receptor subunit alpha | 0 | 0 | 5 | 5 |
| Cytochrome c1, heme protein, mitochondrial | 0 | 0 | 7 | 7 |
| Hepatocyte growth factor receptor | 0 | 3 | 9 | 12 |
| Tyrosine-protein kinase HCK | 0 | 4 | 9 | 13 |
| Platelet-derived growth factor receptor beta | 0 | 5 | 9 | 14 |
| Serine/threonine-protein kinase A-Raf | 0 | 1 | 7 | 8 |
| Glycogen phosphorylase, brain form | 0 | 0 | 7 | 7 |
| Breakpoint cluster region protein | 0 | 5 | 9 | 16 |
| Serine/threonine-protein kinase pim-1 | 0 | 1 | 9 | 10 |
| Fibroblast growth factor receptor 1 | 0 | 6 | 10 | 16 |
| DNA topoisomerase 2-alpha | 0 | 3 | 7 | 17 |
| Cyclin-dependent kinase 4 | 0 | 1 | 9 | 10 |
| ADP/ATP translocase 3 | 0 | 0 | 7 | 7 |
| Inosine-5'-monophosphate dehydrogenase 2 | 0 | 0 | 6 | 6 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 9 | 9 | 18 |
| cAMP-dependent protein kinase type II-alpha regulatory subunit | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase B-raf | 0 | 5 | 10 | 15 |
| Phosphorylase b kinase gamma catalytic chain, liver/testis isoform | 0 | 0 | 9 | 9 |
| Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 3 | 9 | 12 |
| Tyrosine-protein kinase Fer | 0 | 0 | 9 | 9 |
| Protein kinase C alpha type | 0 | 3 | 8 | 11 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 9 | 10 |
| General transcription and DNA repair factor IIH helicase subunit XPD | 0 | 0 | 7 | 7 |
| Casein kinase II subunit alpha' | 0 | 2 | 9 | 11 |
| Ras-related protein Rab-6A | 0 | 0 | 6 | 6 |
| Ephrin type-A receptor 1 | 0 | 0 | 9 | 9 |
| Multifunctional protein ADE2 | 0 | 0 | 7 | 7 |
| cAMP-dependent protein kinase catalytic subunit gamma | 0 | 1 | 6 | 7 |
| cAMP-dependent protein kinase catalytic subunit beta | 0 | 1 | 9 | 10 |
| Ferrochelatase, mitochondrial | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase beta-1 | 0 | 1 | 9 | 10 |
| Tyrosine-protein kinase JAK1 | 0 | 1 | 9 | 10 |
| Cyclin-dependent kinase 2 | 0 | 4 | 9 | 13 |
| Beta-adrenergic receptor kinase 1 | 0 | 0 | 7 | 7 |
| Probable ATP-dependent RNA helicase DDX6 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 3 | 0 | 1 | 9 | 10 |
| MAP/microtubule affinity-regulating kinase 3 | 0 | 0 | 9 | 9 |
| Deoxycytidine kinase | 0 | 0 | 7 | 8 |
| Phosphatidylinositol 3-kinase regulatory subunit alpha | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 2 | 9 | 11 |
| Ephrin type-A receptor 2 | 0 | 2 | 9 | 11 |
| Ephrin type-B receptor 2 | 0 | 4 | 10 | 14 |
| Non-receptor tyrosine-protein kinase TYK2 | 0 | 1 | 9 | 10 |
| UMP-CMP kinase | 0 | 0 | 4 | 4 |
| Phosphatidylethanolamine-binding protein 1 | 0 | 0 | 6 | 6 |
| Wee1-like protein kinase | 0 | 0 | 9 | 9 |
| Heme oxygenase 2 | 0 | 0 | 7 | 7 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 7 | 7 |
| DnaJ homolog subfamily A member 1 | 0 | 0 | 7 | 7 |
| RAC-alpha serine/threonine-protein kinase | 0 | 3 | 9 | 12 |
| RAC-beta serine/threonine-protein kinase | 0 | 2 | 9 | 11 |
| Dual specificity protein kinase TTK | 0 | 0 | 9 | 9 |
| DNA replication licensing factor MCM4 | 0 | 0 | 7 | 7 |
| Myosin-10 | 0 | 0 | 4 | 4 |
| Dual specificity mitogen-activated protein kinase kinase 2 | 0 | 3 | 9 | 12 |
| Receptor-type tyrosine-protein kinase FLT3 | 0 | 6 | 9 | 15 |
| Bone morphogenetic protein receptor type-1A | 0 | 0 | 9 | 9 |
| Activin receptor type-1B | 0 | 0 | 9 | 9 |
| TGF-beta receptor type-1 | 0 | 1 | 9 | 10 |
| TGF-beta receptor type-2 | 0 | 0 | 9 | 9 |
| Electron transfer flavoprotein subunit beta | 0 | 0 | 6 | 6 |
| Tyrosine-protein kinase CSK | 0 | 3 | 9 | 12 |
| Glycine--tRNA ligase | 0 | 0 | 7 | 7 |
| Protein kinase C iota type | 0 | 2 | 9 | 11 |
| Exosome RNA helicase MTR4 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit alpha isoform | 0 | 5 | 7 | 12 |
| Serine/threonine-protein kinase mTOR | 0 | 6 | 8 | 14 |
| Tyrosine-protein kinase Tec | 0 | 1 | 9 | 10 |
| Tyrosine-protein kinase ABL2 | 0 | 1 | 9 | 10 |
| Tyrosine-protein kinase FRK | 0 | 0 | 9 | 9 |
| G protein-coupled receptor kinase 6 | 0 | 0 | 6 | 6 |
| Tyrosine-protein kinase SYK | 0 | 1 | 9 | 10 |
| 26S proteasome regulatory subunit 6B | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase 8 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase 9 | 0 | 1 | 9 | 10 |
| Dual specificity mitogen-activated protein kinase kinase 4 | 0 | 0 | 8 | 8 |
| Dual specificity mitogen-activated protein kinase kinase 3 | 0 | 0 | 9 | 9 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 alpha | 0 | 0 | 5 | 5 |
| Casein kinase I isoform alpha | 0 | 2 | 9 | 11 |
| Casein kinase I isoform delta | 0 | 2 | 9 | 11 |
| MAP kinase-activated protein kinase 2 | 0 | 1 | 9 | 10 |
| Elongation factor Tu, mitochondrial | 0 | 0 | 7 | 7 |
| Cysteine--tRNA ligase, cytoplasmic | 0 | 0 | 6 | 6 |
| Casein kinase I isoform epsilon | 0 | 1 | 9 | 10 |
| Very long-chain specific acyl-CoA dehydrogenase, mitochondrial | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK1 | 0 | 0 | 9 | 9 |
| Dual specificity protein kinase CLK2 | 0 | 0 | 9 | 9 |
| Glycogen synthase kinase-3 alpha | 0 | 0 | 9 | 9 |
| Glycogen synthase kinase-3 beta | 0 | 2 | 9 | 11 |
| Cyclin-dependent kinase 7 | 0 | 1 | 9 | 10 |
| Cyclin-dependent kinase 9 | 0 | 0 | 9 | 9 |
| Ras-related protein Rab-27A | 0 | 0 | 6 | 6 |
| Interleukin-1 receptor-associated kinase 1 | 0 | 0 | 9 | 9 |
| Ribosomal protein S6 kinase alpha-3 | 0 | 1 | 9 | 10 |
| Serine/threonine-protein kinase Nek2 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase Nek3 | 0 | 0 | 9 | 9 |
| Dual specificity mitogen-activated protein kinase kinase 6 | 0 | 0 | 9 | 9 |
| LIM domain kinase 1 | 0 | 1 | 9 | 10 |
| LIM domain kinase 2 | 0 | 1 | 9 | 10 |
| Mitogen-activated protein kinase 10 | 0 | 2 | 9 | 11 |
| Tyrosine--tRNA ligase, cytoplasmic | 0 | 0 | 7 | 7 |
| 5'-AMP-activated protein kinase subunit gamma-1 | 0 | 0 | 7 | 8 |
| Ephrin type-B receptor 3 | 0 | 0 | 9 | 9 |
| Ephrin type-A receptor 5 | 0 | 0 | 9 | 9 |
| Ephrin type-B receptor 4 | 0 | 3 | 9 | 12 |
| Ephrin type-A receptor 4 | 0 | 0 | 9 | 9 |
| Adenylate kinase 2, mitochondrial | 0 | 0 | 7 | 7 |
| Adenosine kinase | 0 | 0 | 7 | 7 |
| Ras-related protein Rab-10 | 0 | 0 | 7 | 7 |
| Actin-related protein 3 | 0 | 0 | 7 | 7 |
| Actin-related protein 2 | 0 | 0 | 7 | 7 |
| GTP-binding nuclear protein Ran | 0 | 0 | 7 | 7 |
| Casein kinase I isoform gamma-2 | 0 | 0 | 9 | 9 |
| Cyclin-dependent kinase 3 | 0 | 0 | 8 | 8 |
| Cyclin-dependent kinase 6 | 0 | 1 | 7 | 8 |
| Cyclin-dependent-like kinase 5 | 0 | 0 | 9 | 9 |
| Cyclin-dependent kinase 16 | 0 | 0 | 9 | 9 |
| Cyclin-dependent kinase 17 | 0 | 0 | 9 | 9 |
| ATP-dependent 6-phosphofructokinase, platelet type | 0 | 0 | 7 | 7 |
| Dual specificity mitogen-activated protein kinase kinase 1 | 0 | 6 | 9 | 15 |
| DNA topoisomerase 2-beta | 0 | 2 | 8 | 17 |
| Protein kinase C theta type | 0 | 2 | 9 | 11 |
| Activin receptor type-1 | 0 | 0 | 9 | 9 |
| Macrophage-stimulating protein receptor | 0 | 1 | 9 | 10 |
| Focal adhesion kinase 1 | 0 | 1 | 9 | 10 |
| Protein kinase C zeta type | 0 | 3 | 4 | 7 |
| Protein kinase C delta type | 0 | 3 | 9 | 12 |
| Tyrosine-protein kinase BTK | 0 | 3 | 9 | 12 |
| Activated CDC42 kinase 1 | 0 | 1 | 9 | 10 |
| Epithelial discoidin domain-containing receptor 1 | 0 | 3 | 9 | 12 |
| Potassium voltage-gated channel subfamily H member 2 | 0 | 8 | 0 | 8 |
| Mitogen-activated protein kinase kinase kinase kinase 2 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase 4 | 0 | 0 | 9 | 9 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-1 | 0 | 0 | 9 | 10 |
| Dual specificity mitogen-activated protein kinase kinase 5 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase 7 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase PAK 2 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase 3 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase 1 | 0 | 0 | 9 | 9 |
| Integrin-linked protein kinase | 0 | 0 | 7 | 7 |
| Rho-associated protein kinase 1 | 0 | 0 | 9 | 9 |
| Non-receptor tyrosine-protein kinase TNK1 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase ATR | 0 | 0 | 2 | 2 |
| Calcium/calmodulin-dependent protein kinase type II subunit gamma | 0 | 0 | 9 | 9 |
| Calcium/calmodulin-dependent protein kinase type II subunit delta | 0 | 0 | 9 | 9 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1A | 0 | 1 | 9 | 10 |
| Activin receptor type-2B | 0 | 0 | 9 | 9 |
| Bone morphogenetic protein receptor type-2 | 0 | 0 | 9 | 9 |
| Protein-tyrosine kinase 6 | 0 | 1 | 9 | 10 |
| cGMP-dependent protein kinase 1 | 0 | 0 | 9 | 9 |
| Cyclin-dependent kinase 13 | 0 | 0 | 9 | 9 |
| Inhibitor of nuclear factor kappa-B kinase subunit epsilon | 0 | 0 | 9 | 9 |
| Protein-tyrosine kinase 2-beta | 0 | 0 | 9 | 9 |
| Maternal embryonic leucine zipper kinase | 0 | 0 | 9 | 9 |
| Structural maintenance of chromosomes protein 1A | 0 | 0 | 7 | 7 |
| Chromodomain-helicase-DNA-binding protein 4 | 0 | 0 | 6 | 6 |
| Peroxisomal acyl-coenzyme A oxidase 1 | 0 | 0 | 6 | 6 |
| Ephrin type-A receptor 7 | 0 | 0 | 8 | 8 |
| Delta(24)-sterol reductase | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-1 | 0 | 2 | 9 | 11 |
| Dual specificity testis-specific protein kinase 1 | 0 | 0 | 9 | 9 |
| Myosin light chain kinase, smooth muscle | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase 11 | 0 | 2 | 10 | 12 |
| Serine/threonine-protein kinase STK11 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase N1 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase N2 | 0 | 1 | 9 | 10 |
| Mitogen-activated protein kinase 14 | 0 | 7 | 11 | 18 |
| Calcium/calmodulin-dependent protein kinase type IV | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase 11 | 0 | 0 | 9 | 9 |
| Discoidin domain-containing receptor 2 | 0 | 5 | 9 | 14 |
| AP2-associated protein kinase 1 | 0 | 1 | 9 | 10 |
| Myosin light chain kinase 3 | 0 | 0 | 9 | 9 |
| Putative heat shock protein HSP 90-beta 2 | 0 | 0 | 7 | 7 |
| Rab-like protein 3 | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase MRCK alpha | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase MRCK gamma | 0 | 0 | 9 | 9 |
| Acyl-CoA dehydrogenase family member 10 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase N3 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase ULK3 | 0 | 0 | 9 | 9 |
| Rapamycin-insensitive companion of mTOR | 0 | 2 | 0 | 2 |
| Uncharacterized protein FLJ45252 | 0 | 0 | 7 | 7 |
| Acyl-CoA dehydrogenase family member 11 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase/endoribonuclease IRE2 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase MARK2 | 0 | 0 | 9 | 9 |
| ATP-dependent RNA helicase DHX30 | 0 | 0 | 5 | 5 |
| Serine/threonine-protein kinase TAO1 | 0 | 0 | 9 | 9 |
| STE20-related kinase adapter protein alpha | 0 | 0 | 7 | 7 |
| Myosin-14 | 0 | 0 | 7 | 7 |
| AarF domain-containing protein kinase 1 | 0 | 0 | 7 | 7 |
| ATP-dependent RNA helicase DDX42 | 0 | 0 | 4 | 4 |
| Mitogen-activated protein kinase kinase kinase kinase 3 | 0 | 1 | 9 | 10 |
| MAP kinase-activated protein kinase 5 | 0 | 1 | 9 | 10 |
| Regulatory-associated protein of mTOR | 0 | 3 | 0 | 3 |
| Misshapen-like kinase 1 | 0 | 0 | 9 | 9 |
| Atypical kinase COQ8A, mitochondrial | 0 | 0 | 9 | 9 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 gamma | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase 15 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase Nek9 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase Nek7 | 0 | 0 | 8 | 8 |
| ATP-dependent RNA helicase DDX1 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase kinase 1 | 0 | 0 | 9 | 9 |
| Aurora kinase B | 0 | 2 | 9 | 11 |
| MAP/microtubule affinity-regulating kinase 4 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase Nek1 | 0 | 0 | 9 | 9 |
| PAS domain-containing serine/threonine-protein kinase | 0 | 0 | 6 | 6 |
| Calcium/calmodulin-dependent protein kinase kinase 2 | 0 | 0 | 9 | 9 |
| EKC/KEOPS complex subunit TP53RK | 0 | 0 | 7 | 7 |
| Dual specificity testis-specific protein kinase 2 | 0 | 0 | 5 | 5 |
| Membrane-associated tyrosine- and threonine-specific cdc2-inhibitory kinase | 0 | 2 | 9 | 11 |
| Mitogen-activated protein kinase kinase kinase 5 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase 3 | 0 | 0 | 9 | 9 |
| Target of rapamycin complex 2 subunit MAPKAP1 | 0 | 2 | 0 | 2 |
| Eukaryotic translation initiation factor 2-alpha kinase 1 | 0 | 0 | 9 | 9 |
| Target of rapamycin complex subunit LST8 | 0 | 3 | 0 | 3 |
| Nucleolar GTP-binding protein 1 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase D2 | 0 | 0 | 9 | 9 |
| NUAK family SNF1-like kinase 2 | 0 | 0 | 8 | 8 |
| RNA cytidine acetyltransferase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase SIK2 | 0 | 1 | 9 | 10 |
| STE20-like serine/threonine-protein kinase | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase TAO3 | 0 | 0 | 9 | 9 |
| dCTP pyrophosphatase 1 | 0 | 0 | 7 | 7 |
| Dual specificity protein kinase CLK4 | 0 | 0 | 9 | 9 |
| Casein kinase I isoform gamma-1 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase PAK 6 | 0 | 0 | 8 | 8 |
| Phenylalanine--tRNA ligase beta subunit | 0 | 0 | 7 | 7 |
| Isoleucine--tRNA ligase, mitochondrial | 0 | 0 | 6 | 6 |
| BMP-2-inducible protein kinase | 0 | 0 | 9 | 9 |
| Obg-like ATPase 1 | 0 | 0 | 7 | 7 |
| Midasin | 0 | 0 | 7 | 7 |
| Interleukin-1 receptor-associated kinase 4 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase 20 | 0 | 0 | 9 | 9 |
| Cyclin-dependent kinase 12 | 0 | 0 | 7 | 7 |
| NADH dehydrogenase [ubiquinone] 1 alpha subcomplex subunit 13 | 0 | 0 | 6 | 6 |
| Serine/threonine-protein kinase pim-2 | 0 | 0 | 8 | 8 |
| Serine/threonine-protein kinase 26 | 0 | 0 | 9 | 9 |
| Succinate--CoA ligase [ADP-forming] subunit beta, mitochondrial | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase NLK | 0 | 1 | 9 | 10 |
| 5'-AMP-activated protein kinase subunit gamma-2 | 0 | 0 | 7 | 8 |
| Serine/threonine-protein kinase TBK1 | 0 | 0 | 9 | 9 |
| Septin-9 | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-6 | 0 | 0 | 9 | 9 |
| TRAF2 and NCK-interacting protein kinase | 0 | 1 | 9 | 10 |
| Serine/threonine-protein kinase TAO2 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase ICK | 0 | 0 | 9 | 9 |
| RAC-gamma serine/threonine-protein kinase | 0 | 1 | 9 | 10 |
| Serine/threonine-protein kinase 38-like | 0 | 0 | 8 | 8 |
| Serine/threonine-protein kinase SIK3 | 0 | 1 | 9 | 10 |
| Mitogen-activated protein kinase kinase kinase 2 | 0 | 0 | 9 | 9 |
| Thyroid hormone receptor-associated protein 3 | 0 | 0 | 5 | 5 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 1B | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase kinase 5 | 0 | 0 | 9 | 9 |
| Receptor-interacting serine/threonine-protein kinase 3 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase MRCK beta | 0 | 0 | 9 | 9 |
| Interleukin-1 receptor-associated kinase 3 | 0 | 0 | 9 | 9 |
| Serine/threonine-protein kinase 24 | 0 | 0 | 9 | 9 |
| Casein kinase I isoform gamma-3 | 0 | 0 | 9 | 9 |
| Mitogen-activated protein kinase kinase kinase 4 | 0 | 0 | 9 | 9 |
| cytochrome P450 family 3 subfamily A polypeptide 4 | 21 | 0 | 0 | 21 |
| EWS/FLI fusion protein | 29 | 0 | 0 | 30 |
| G | 12 | 0 | 0 | 12 |
| cytochrome P450 2D6 | 12 | 0 | 0 | 12 |
| HLA class I histocompatibility antigen, B alpha chain | 12 | 0 | 0 | 12 |
| Fibroblast growth factor receptor 2 | 0 | 3 | 7 | 10 |
| Fibroblast growth factor receptor 4 | 0 | 2 | 7 | 9 |
| Fibroblast growth factor receptor 3 | 0 | 3 | 8 | 11 |
| Fibroblast growth factor receptor 4 | 0 | 1 | 0 | 1 |
| Inositol hexakisphosphate kinase 1 | 12 | 0 | 0 | 12 |
| Smoothened homolog | 0 | 1 | 0 | 1 |
| cytochrome P450 2C9, partial | 12 | 0 | 0 | 12 |
| dopamine D1 receptor | 2 | 0 | 0 | 2 |
| thioredoxin reductase | 18 | 0 | 0 | 18 |
| GLS protein | 8 | 0 | 0 | 8 |
| Thrombopoietin | 6 | 0 | 0 | 6 |
| hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 12 | 0 | 0 | 12 |
| cytochrome P450 2D6 isoform 1 | 9 | 0 | 0 | 9 |
| cytochrome P450 2C19 precursor | 5 | 0 | 0 | 5 |
| ras-related protein Rab-9A | 11 | 0 | 0 | 11 |
| histone acetyltransferase KAT2A isoform 1 | 14 | 0 | 0 | 14 |
| lethal factor (plasmid) | 10 | 0 | 0 | 10 |
| POU domain, class 2, transcription factor 1 | 0 | 0 | 0 | 1 |
| Spike glycoprotein | 10 | 0 | 3 | 13 |
| ATP-dependent phosphofructokinase | 15 | 0 | 0 | 15 |
| Bromodomain-containing protein 4 | 0 | 3 | 0 | 3 |
| Bromodomain-containing protein 2 | 0 | 2 | 0 | 2 |
| Histone acetyltransferase p300 | 0 | 3 | 0 | 3 |
| Histone deacetylase 1 | 0 | 15 | 4 | 21 |
| Bromodomain-containing protein 3 | 0 | 2 | 0 | 2 |
| Histone deacetylase 6 | 0 | 11 | 2 | 15 |
| Chain A, Apoptosis regulator Bcl-X | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 11 | 0 | 2 | 0 | 2 |
| Beta-casein | 0 | 1 | 0 | 1 |
| Apoptosis regulator Bcl-2 | 0 | 5 | 4 | 9 |
| Alpha-1B adrenergic receptor | 0 | 6 | 0 | 6 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Adenosine receptor A2a | 0 | 2 | 0 | 2 |
| BH3-interacting domain death agonist | 0 | 2 | 0 | 2 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 homolog | 0 | 0 | 1 | 1 |
| Apoptosis regulator BAX | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 1 | 0 | 5 | 3 | 8 |
| Induced myeloid leukemia cell differentiation protein Mcl-1 | 0 | 5 | 0 | 5 |
| Aspartyl/asparaginyl beta-hydroxylase | 0 | 3 | 0 | 3 |
| Bcl-2-related protein A1 | 0 | 1 | 1 | 2 |
| Bcl-2 homologous antagonist/killer | 0 | 2 | 1 | 3 |
| Bcl-2-like protein 2 | 0 | 4 | 0 | 4 |
| Bcl2-associated agonist of cell death | 0 | 2 | 0 | 2 |
| Bcl-2-binding component 3, isoforms 1/2 | 0 | 1 | 0 | 1 |
| Bcl-2-like protein 10 | 0 | 1 | 0 | 1 |
| Chain A, Ferritin light chain | 16 | 0 | 0 | 16 |
| TDP1 protein | 39 | 0 | 0 | 39 |
| Microtubule-associated protein tau | 18 | 0 | 0 | 18 |
| Smad3 | 12 | 0 | 0 | 12 |
| aldehyde dehydrogenase 1 family, member A1 | 23 | 0 | 0 | 23 |
| alpha-galactosidase | 4 | 0 | 0 | 4 |
| 15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 10 | 0 | 0 | 10 |
| flap endonuclease 1 | 8 | 0 | 0 | 8 |
| DNA polymerase iota isoform a (long) | 18 | 0 | 0 | 18 |
| Acetylcholinesterase | 0 | 9 | 0 | 9 |
| Chain A, Beta-lactamase | 12 | 0 | 0 | 12 |
| Chain A, JmjC domain-containing histone demethylation protein 3A | 6 | 0 | 0 | 6 |
| Chain A, 2-oxoglutarate Oxygenase | 15 | 0 | 0 | 15 |
| acetylcholinesterase | 11 | 0 | 0 | 11 |
| glp-1 receptor, partial | 12 | 0 | 0 | 12 |
| pregnane X receptor | 8 | 0 | 0 | 8 |
| phosphopantetheinyl transferase | 14 | 0 | 0 | 14 |
| hypoxia-inducible factor 1 alpha subunit | 12 | 0 | 0 | 12 |
| RAR-related orphan receptor gamma | 28 | 0 | 0 | 28 |
| SMAD family member 2 | 7 | 0 | 0 | 7 |
| SMAD family member 3 | 7 | 0 | 0 | 7 |
| GLI family zinc finger 3 | 27 | 0 | 0 | 27 |
| AR protein | 29 | 0 | 0 | 29 |
| apical membrane antigen 1, AMA1 | 6 | 0 | 0 | 6 |
| caspase 7, apoptosis-related cysteine protease | 9 | 0 | 0 | 9 |
| estrogen receptor 2 (ER beta) | 19 | 0 | 0 | 19 |
| nuclear receptor subfamily 1, group I, member 3 | 23 | 0 | 0 | 23 |
| progesterone receptor | 18 | 0 | 0 | 18 |
| nonstructural protein 1 | 6 | 0 | 0 | 6 |
| glucocorticoid receptor [Homo sapiens] | 29 | 0 | 0 | 29 |
| retinoic acid nuclear receptor alpha variant 1 | 29 | 0 | 0 | 29 |
| retinoid X nuclear receptor alpha | 24 | 0 | 0 | 24 |
| estrogen-related nuclear receptor alpha | 34 | 0 | 0 | 34 |
| farnesoid X nuclear receptor | 21 | 0 | 0 | 21 |
| pregnane X nuclear receptor | 22 | 0 | 0 | 22 |
| estrogen nuclear receptor alpha | 31 | 0 | 0 | 31 |
| 67.9K protein | 17 | 0 | 0 | 17 |
| glucocerebrosidase | 9 | 0 | 0 | 9 |
| bromodomain adjacent to zinc finger domain 2B | 7 | 0 | 0 | 7 |
| peroxisome proliferator-activated receptor delta | 20 | 0 | 0 | 20 |
| peroxisome proliferator activated receptor gamma | 20 | 0 | 0 | 20 |
| vitamin D (1,25- dihydroxyvitamin D3) receptor | 16 | 0 | 0 | 16 |
| caspase-3 | 9 | 0 | 0 | 9 |
| IDH1 | 15 | 0 | 0 | 15 |
| euchromatic histone-lysine N-methyltransferase 2 | 25 | 0 | 0 | 25 |
| cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 22 | 0 | 0 | 22 |
| thyroid stimulating hormone receptor | 16 | 0 | 0 | 16 |
| activating transcription factor 6 | 15 | 0 | 0 | 15 |
| thyrotropin-releasing hormone receptor | 4 | 0 | 0 | 4 |
| nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 6 | 0 | 0 | 6 |
| v-jun sarcoma virus 17 oncogene homolog (avian) | 11 | 0 | 0 | 11 |
| Histone H2A.x | 14 | 0 | 0 | 14 |
| Caspase-7 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform a | 15 | 0 | 0 | 15 |
| caspase-3 | 7 | 0 | 0 | 7 |
| thyroid hormone receptor beta isoform 2 | 23 | 0 | 0 | 23 |
| heat shock protein beta-1 | 8 | 0 | 0 | 8 |
| ubiquitin-conjugating enzyme E2 N | 0 | 3 | 0 | 3 |
| nuclear factor NF-kappa-B p105 subunit isoform 1 | 3 | 0 | 1 | 4 |
| nuclear factor erythroid 2-related factor 2 isoform 1 | 25 | 0 | 0 | 25 |
| urokinase-type plasminogen activator precursor | 9 | 0 | 0 | 9 |
| plasminogen precursor | 9 | 0 | 0 | 9 |
| urokinase plasminogen activator surface receptor precursor | 9 | 0 | 0 | 9 |
| nuclear receptor ROR-gamma isoform 1 | 15 | 0 | 0 | 15 |
| geminin | 30 | 0 | 0 | 30 |
| lamin isoform A-delta10 | 22 | 0 | 0 | 22 |
| neuropeptide S receptor isoform A | 4 | 0 | 0 | 4 |
| Phospholipase D2 | 0 | 1 | 0 | 1 |
| Voltage-dependent calcium channel gamma-2 subunit | 20 | 0 | 0 | 20 |
| Estrogen receptor | 0 | 6 | 1 | 9 |
| Cellular tumor antigen p53 | 25 | 2 | 0 | 27 |
| Aromatase | 0 | 4 | 0 | 4 |
| Glutamate receptor 2 | 21 | 0 | 0 | 21 |
| Estrogen-related receptor gamma | 0 | 2 | 1 | 3 |
| Phospholipase D1 | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 5 | 1 | 6 |
| ATPase family AAA domain-containing protein 5 | 20 | 0 | 0 | 20 |
| Ataxin-2 | 24 | 0 | 0 | 24 |
| Chain A, Lck Kinase | 0 | 1 | 0 | 1 |
| Chain A, BCL-2-RELATED PROTEIN A1 | 0 | 0 | 0 | 2 |
| Chain A, Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Chain A, Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Skn7p | 0 | 0 | 0 | 1 |
| regulator of G-protein signaling 4 | 14 | 0 | 0 | 14 |
| LAP4 | 0 | 0 | 1 | 1 |
| RPL19A | 0 | 0 | 2 | 2 |
| nuclear factor erythroid 2-related factor 2 isoform 2 | 11 | 0 | 0 | 11 |
| amino acid transporter AGP1 | 0 | 0 | 1 | 1 |
| survival motor neuron protein isoform d | 17 | 0 | 0 | 17 |
| Tyrosine-protein kinase JAK2 | 0 | 2 | 8 | 10 |
| Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 2 | 5 |
| Proto-oncogene tyrosine-protein kinase LCK | 0 | 3 | 0 | 3 |
| Ephrin type-A receptor 3 | 0 | 0 | 8 | 8 |
| Alpha-synuclein | 6 | 3 | 1 | 10 |
| Tyrosine-protein kinase ZAP-70 | 0 | 1 | 7 | 8 |
| TAR DNA-binding protein 43 | 4 | 0 | 0 | 4 |
| HSP40, subfamily A [Plasmodium falciparum 3D7] | 0 | 0 | 0 | 1 |
| cytochrome P450 2C9 precursor | 3 | 0 | 0 | 3 |
| cytochrome P450 3A4 isoform 1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit pi | 17 | 0 | 0 | 17 |
| Androgen receptor | 0 | 6 | 0 | 6 |
| Gamma-aminobutyric acid receptor subunit beta-1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit delta | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-2 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-5 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-3 | 17 | 0 | 0 | 17 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Cannabinoid receptor 1 | 0 | 2 | 1 | 3 |
| Gamma-aminobutyric acid receptor subunit gamma-1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-2 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-4 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit gamma-3 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit alpha-6 | 17 | 0 | 0 | 17 |
| Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
| Histamine H2 receptor | 13 | 1 | 0 | 14 |
| Gamma-aminobutyric acid receptor subunit alpha-1 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-3 | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit beta-2 | 17 | 0 | 0 | 17 |
| GABA theta subunit | 17 | 0 | 0 | 17 |
| Gamma-aminobutyric acid receptor subunit epsilon | 17 | 0 | 0 | 17 |
| Chain A, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain B, HADH2 protein | 9 | 0 | 0 | 9 |
| Chain A, Cruzipain | 7 | 0 | 0 | 7 |
| interleukin 8 | 9 | 0 | 0 | 9 |
| tumor necrosis factor | 1 | 0 | 0 | 1 |
| vitamin D3 receptor isoform VDRA | 16 | 0 | 0 | 16 |
| peripheral myelin protein 22 | 15 | 0 | 0 | 15 |
| Cytochrome P450 1A2 | 0 | 7 | 1 | 8 |
| Cytochrome P450 3A4 | 0 | 19 | 1 | 21 |
| Cytochrome P450 2D6 | 0 | 7 | 1 | 8 |
| Cytochrome P450 2C9 | 0 | 8 | 1 | 9 |
| Cytochrome P450 2C19 | 0 | 9 | 1 | 10 |
| Nuclear receptor ROR-gamma | 10 | 1 | 1 | 12 |
| Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 6 | 0 | 7 |
| Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 17 | 0 | 0 | 17 |
| Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 8 | 0 | 0 | 8 |
| huntingtin isoform 2 | 9 | 0 | 0 | 9 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 0 | 1 | 0 | 1 |
| DNA polymerase beta | 0 | 1 | 0 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase alpha catalytic subunit | 0 | 2 | 1 | 3 |
| DNA polymerase delta catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase catalytic subunit | 0 | 1 | 0 | 1 |
| DNA polymerase subunit gamma-1 | 0 | 1 | 0 | 1 |
| DNA polymerase lambda | 0 | 1 | 0 | 1 |
| DNA polymerase kappa isoform 1 | 18 | 0 | 0 | 18 |
| Integrin beta-3 | 8 | 2 | 0 | 10 |
| Integrin beta-1 | 0 | 2 | 0 | 2 |
| Integrin alpha-V | 0 | 1 | 0 | 1 |
| Integrin alpha-IIb | 8 | 2 | 0 | 10 |
| Integrin alpha-5 | 0 | 1 | 0 | 1 |
| Integrin beta-5 | 0 | 1 | 0 | 1 |
| ATAD5 protein, partial | 13 | 0 | 0 | 13 |
| Fumarate hydratase | 22 | 0 | 0 | 22 |
| NFKB1 protein, partial | 4 | 0 | 0 | 4 |
| polyprotein | 22 | 0 | 0 | 22 |
| Parkin | 8 | 0 | 0 | 8 |
| arylsulfatase A | 6 | 0 | 0 | 6 |
| aryl hydrocarbon receptor | 19 | 0 | 0 | 19 |
| Bloom syndrome protein isoform 1 | 13 | 0 | 0 | 13 |
| peripheral myelin protein 22 isoform 1 | 6 | 0 | 0 | 6 |
| hemoglobin subunit beta | 4 | 0 | 0 | 4 |
| cellular tumor antigen p53 isoform a | 10 | 0 | 0 | 10 |
| chromobox protein homolog 1 | 18 | 0 | 0 | 18 |
| serine/threonine-protein kinase mTOR isoform 1 | 11 | 0 | 0 | 11 |
| muscarinic acetylcholine receptor M1 | 3 | 0 | 0 | 3 |
| Adenosine receptor A3 | 0 | 5 | 0 | 5 |
| DNA (cytosine-5)-methyltransferase 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A2a | 0 | 5 | 0 | 5 |
| Adenosine receptor A1 | 0 | 5 | 0 | 5 |
| D(1A) dopamine receptor | 9 | 0 | 0 | 9 |
| Multidrug and toxin extrusion protein 1 | 0 | 3 | 0 | 3 |
| Histone-lysine N-methyltransferase EHMT2 | 0 | 1 | 0 | 1 |
| Chain A, Putative fructose-1,6-bisphosphate aldolase | 7 | 0 | 0 | 7 |
| thyroid stimulating hormone receptor | 7 | 0 | 0 | 7 |
| Telomerase reverse transcriptase | 0 | 2 | 0 | 2 |
| Acetylcholinesterase | 0 | 4 | 0 | 4 |
| Lysine-specific histone demethylase 1A | 0 | 4 | 0 | 4 |
| Neuraminidase | 0 | 1 | 0 | 1 |
| Neuraminidase | 0 | 2 | 0 | 2 |
| Cholinesterase | 0 | 5 | 0 | 5 |
| Tyrosine-protein phosphatase non-receptor type 1 | 0 | 4 | 0 | 6 |
| Aldo-keto reductase family 1 member C3 | 0 | 1 | 0 | 1 |
| Prolyl endopeptidase | 0 | 2 | 0 | 2 |
| Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
| Cholinesterase | 0 | 4 | 0 | 4 |
| Inositol monophosphatase 1 | 9 | 0 | 0 | 9 |
| Cytochrome P450 1B1 | 0 | 4 | 0 | 4 |
| Chain H, Proteasome component PUP1 | 0 | 1 | 0 | 1 |
| Chain I, Proteasome component PUP3 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Chain K, Proteasome component PRE2 | 0 | 1 | 0 | 1 |
| Chain L, Proteasome component C5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-11 | 0 | 1 | 0 | 1 |
| nuclear receptor subfamily 1, group I, member 2 | 5 | 0 | 0 | 5 |
| 26S proteasome non-ATPase regulatory subunit 11 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 12 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 14 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 11 | 1 | 14 |
| ATP-binding cassette sub-family C member 3 | 0 | 19 | 0 | 19 |
| Multidrug resistance-associated protein 4 | 0 | 19 | 0 | 19 |
| 26S proteasome non-ATPase regulatory subunit 3 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 12 | 0 | 6 | 0 | 6 |
| Bile salt export pump | 0 | 24 | 0 | 24 |
| Prothrombin | 0 | 1 | 0 | 3 |
| Chymotrypsinogen A | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 1 | 0 | 9 | 0 | 9 |
| Carbonic anhydrase 2 | 0 | 9 | 0 | 9 |
| Carbonic anhydrase 3 | 0 | 4 | 0 | 4 |
| Cathepsin B | 0 | 1 | 0 | 1 |
| Neutrophil elastase | 0 | 2 | 0 | 2 |
| Cathepsin G | 0 | 2 | 0 | 2 |
| Lysosomal protective protein | 0 | 1 | 0 | 1 |
| Chymotrypsinogen B | 0 | 2 | 0 | 2 |
| 26S proteasome regulatory subunit 6A | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p105 subunit | 0 | 2 | 0 | 2 |
| Proteasome subunit beta type-1 | 0 | 1 | 0 | 2 |
| Carbonic anhydrase 4 | 0 | 4 | 0 | 4 |
| Carbonic anhydrase 6 | 0 | 5 | 0 | 5 |
| Chymase | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-1 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-2 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-9 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-5 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-4 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-6 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-5 | 0 | 3 | 0 | 4 |
| Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 4 |
| 26S proteasome regulatory subunit 7 | 0 | 1 | 0 | 1 |
| Lon protease homolog, mitochondrial | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-10 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 7 | 0 | 5 | 0 | 5 |
| 26S proteasome non-ATPase regulatory subunit 8 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-3 | 0 | 1 | 0 | 1 |
| Proteasome subunit beta type-2 | 0 | 1 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 7 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 4 | 0 | 1 | 0 | 1 |
| 26S proteasome complex subunit SEM1 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha type-6 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 4 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 8 | 0 | 1 | 0 | 1 |
| 26S proteasome regulatory subunit 10B | 0 | 1 | 0 | 1 |
| Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
| Nuclear factor NF-kappa-B p100 subunit | 0 | 2 | 0 | 2 |
| Transcription factor p65 | 0 | 2 | 0 | 2 |
| 26S proteasome non-ATPase regulatory subunit 2 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 6 | 0 | 1 | 0 | 1 |
| Proteasomal ubiquitin receptor ADRM1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 9 | 0 | 8 | 0 | 8 |
| ATP-dependent Clp protease proteolytic subunit | 0 | 1 | 1 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Proteasome subunit alpha-type 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 12 | 3 | 17 |
| Canalicular multispecific organic anion transporter 1 | 0 | 21 | 0 | 22 |
| Proteasome subunit beta type-7 | 0 | 1 | 0 | 1 |
| 26S proteasome non-ATPase regulatory subunit 1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 15 | 0 | 4 | 0 | 4 |
| Histone deacetylase 8 | 0 | 11 | 1 | 14 |
| Carbonic anhydrase 14 | 0 | 5 | 0 | 5 |
| 26S proteasome non-ATPase regulatory subunit 13 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase 5B, mitochondrial | 0 | 4 | 0 | 4 |
| DNA topoisomerase | 0 | 1 | 0 | 1 |
| 15-lipoxygenase, partial | 7 | 0 | 0 | 7 |
| putative alpha-glucosidase | 1 | 0 | 0 | 1 |
| lysosomal alpha-glucosidase preproprotein | 5 | 0 | 0 | 5 |
| eukaryotic translation initiation factor 2-alpha kinase 3 isoform 1 precursor | 0 | 0 | 1 | 1 |
| M-phase phosphoprotein 8 | 6 | 0 | 0 | 6 |
| muscleblind-like protein 1 isoform 1 | 7 | 0 | 0 | 7 |
| relaxin receptor 1 isoform 1 | 1 | 0 | 0 | 1 |
| Type-2 restriction enzyme ScaI | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-2-alpha | 0 | 1 | 0 | 1 |
| Tyrosyl-DNA phosphodiesterase 2 | 0 | 1 | 0 | 1 |
| Deoxyribonuclease-1 | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme PstI | 0 | 1 | 0 | 1 |
| Type-2 restriction enzyme EcoRI | 0 | 1 | 0 | 1 |
| DNA ligase | 0 | 1 | 0 | 1 |
| Heterogeneous nuclear ribonucleoprotein A1 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 1 | 0 | 3 | 3 | 13 |
| Type-2 restriction enzyme BamHI | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 1 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 2 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 4 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 3 | 0 | 1 | 0 | 1 |
| Somatostatin receptor type 5 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2B | 0 | 7 | 0 | 7 |
| Type-2 restriction enzyme HindIII | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 8 | 2 | 13 |
| Ribonuclease pancreatic | 0 | 1 | 0 | 1 |
| DNA topoisomerase 1 | 0 | 2 | 0 | 3 |
| DNA topoisomerase 1 | 0 | 1 | 0 | 1 |
| Integrase | 0 | 3 | 0 | 3 |
| Histone deacetylase 7 | 0 | 8 | 1 | 11 |
| DNA topoisomerase type IB small subunit | 0 | 0 | 1 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 7 | 1 | 10 |
| Histone deacetylase 11 | 0 | 8 | 1 | 11 |
| Tyrosyl-DNA phosphodiesterase 1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 9 | 0 | 7 | 1 | 10 |
| Histone deacetylase 5 | 0 | 8 | 1 | 11 |
| Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 10 | 0 | 0 | 10 |
| histone-lysine N-methyltransferase 2A isoform 2 precursor | 6 | 0 | 0 | 6 |
| Chain A, Protein kinase CK2, alpha Subunit | 0 | 1 | 0 | 1 |
| Chain A, PROTEIN KINASE CK2, alpha SUBUNIT | 0 | 1 | 0 | 1 |
| Chain A, Protein Kinase Ck2, Alpha Subunit | 0 | 1 | 0 | 1 |
| endonuclease IV | 6 | 0 | 0 | 6 |
| NPC intracellular cholesterol transporter 1 precursor | 7 | 0 | 0 | 7 |
| mitogen-activated protein kinase 1 | 7 | 0 | 0 | 7 |
| Serine/threonine-protein kinase Sgk1 | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
| Cyclin-A2 | 0 | 2 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 2 | 0 | 2 |
| Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
| Casein kinase II subunit alpha | 0 | 2 | 7 | 9 |
| Cyclin-A1 | 0 | 2 | 0 | 2 |
| Casein kinase II subunit alpha 3 | 0 | 2 | 0 | 2 |
| Single-stranded DNA cytosine deaminase | 2 | 0 | 0 | 2 |
| Chain A, Neutrophil gelatinase-associated lipocalin | 0 | 0 | 1 | 1 |
| Nrf2 | 2 | 0 | 0 | 2 |
| thioredoxin glutathione reductase | 4 | 0 | 0 | 4 |
| heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 10 | 0 | 0 | 10 |
| parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 3 | 0 | 0 | 3 |
| DNA polymerase beta | 6 | 0 | 0 | 6 |
| peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 6 | 0 | 0 | 6 |
| DNA polymerase eta isoform 1 | 5 | 0 | 0 | 5 |
| lethal(3)malignant brain tumor-like protein 1 isoform I | 2 | 0 | 0 | 2 |
| DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 2 | 2 | 0 | 4 |
| Polyunsaturated fatty acid lipoxygenase ALOX15B | 11 | 0 | 0 | 11 |
| 3-dehydroquinate synthase | 0 | 1 | 0 | 2 |
| Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 2 | 0 | 2 |
| Matrix metalloproteinase-9 | 0 | 3 | 0 | 3 |
| Prolyl 4-hydroxylase subunit alpha-1 | 0 | 2 | 0 | 2 |
| Potassium-transporting ATPase subunit beta | 0 | 0 | 0 | 1 |
| Potassium-transporting ATPase alpha chain 1 | 0 | 0 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Autoinducer 2-binding periplasmic protein LuxP | 0 | 1 | 0 | 1 |
| E3 ubiquitin-protein ligase Mdm2 | 1 | 4 | 1 | 6 |
| Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
| Arginase-1 | 0 | 1 | 0 | 1 |
| Carbonic anhydrase | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 3 | 0 | 2 | 0 | 2 |
| Carbonic anhydrase 13 | 0 | 2 | 0 | 2 |
| phosphoglycerate kinase | 2 | 0 | 0 | 2 |
| Luciferase | 13 | 0 | 0 | 13 |
| PAX8 | 0 | 0 | 0 | 1 |
| USP1 protein, partial | 16 | 0 | 0 | 16 |
| nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
| steroidogenic factor 1 | 0 | 1 | 0 | 1 |
| caspase-1 isoform alpha precursor | 3 | 0 | 0 | 3 |
| Solute carrier family 22 member 3 | 0 | 2 | 0 | 2 |
| Tubulin alpha-1A chain | 0 | 2 | 1 | 3 |
| Tubulin beta chain | 0 | 2 | 1 | 3 |
| Plasma kallikrein | 0 | 1 | 0 | 2 |
| Tubulin beta-4A chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Tubulin beta chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 8 | 1 | 14 |
| Tubulin alpha-3C chain | 0 | 2 | 2 | 5 |
| ATP-dependent translocase ABCB1 | 0 | 2 | 0 | 2 |
| Tubulin alpha-1B chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-4A chain | 0 | 2 | 2 | 5 |
| Tubulin beta-4B chain | 0 | 2 | 2 | 5 |
| Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
| Tubulin beta-3 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2A chain | 0 | 2 | 2 | 5 |
| Tubulin polymerization-promoting protein | 0 | 0 | 1 | 1 |
| Tubulin beta-8 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 4 | 0 | 4 |
| Tubulin alpha-3E chain | 0 | 2 | 2 | 5 |
| Tubulin alpha-1A chain | 0 | 2 | 2 | 5 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 0 | 3 |
| Similar to alpha-tubulin isoform 1 | 0 | 3 | 0 | 3 |
| CREB-binding protein | 1 | 1 | 0 | 2 |
| Tubulin alpha-1C chain | 0 | 2 | 2 | 5 |
| Tubulin beta-6 chain | 0 | 2 | 2 | 5 |
| Tubulin beta-2B chain | 0 | 2 | 2 | 5 |
| Tubulin beta-1 chain | 0 | 2 | 2 | 5 |
| Leukotriene C4 synthase | 0 | 0 | 7 | 7 |
| tyrosine-protein kinase Yes | 10 | 0 | 0 | 10 |
| Cell division cycle 7-related protein kinase | 0 | 0 | 3 | 3 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit delta isoform | 0 | 3 | 7 | 10 |
| Serine/threonine-protein kinase 25 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit beta | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase RIO3 | 0 | 0 | 7 | 7 |
| Dual specificity mitogen-activated protein kinase kinase 7 | 0 | 0 | 7 | 7 |
| Inhibitor of nuclear factor kappa-B kinase subunit beta | 0 | 1 | 7 | 9 |
| Peripheral plasma membrane protein CASK | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase DCLK1 | 0 | 0 | 7 | 7 |
| Inhibitor of nuclear factor kappa-B kinase subunit alpha | 0 | 1 | 7 | 8 |
| Muscle, skeletal receptor tyrosine-protein kinase | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase 13 | 0 | 2 | 8 | 10 |
| Phosphatidylinositol 3,4,5-trisphosphate 5-phosphatase 2 | 0 | 1 | 0 | 1 |
| 3-phosphoinositide-dependent protein kinase 1 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 13 | 0 | 0 | 7 | 7 |
| Death-associated protein kinase 3 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 7 | 0 | 0 | 7 | 7 |
| NUAK family SNF1-like kinase 1 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 gamma | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit gamma | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 3 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase-like 5 | 0 | 0 | 8 | 8 |
| Serine/threonine-protein kinase 17B | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 14 | 0 | 0 | 7 | 7 |
| Sodium-dependent phosphate transport protein 2B | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase OSR1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Chk2 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase ABL1 | 0 | 3 | 0 | 3 |
| RAF proto-oncogene serine/threonine-protein kinase | 0 | 5 | 7 | 12 |
| HLA class II histocompatibility antigen gamma chain | 0 | 1 | 0 | 1 |
| Receptor tyrosine-protein kinase erbB-2 | 0 | 5 | 7 | 12 |
| Nucleophosmin | 0 | 1 | 0 | 1 |
| Macrophage colony-stimulating factor 1 receptor | 0 | 6 | 7 | 13 |
| Proto-oncogene tyrosine-protein kinase ROS | 0 | 2 | 7 | 9 |
| Tyrosine-protein kinase Fgr | 0 | 1 | 8 | 9 |
| Wee1-like protein kinase 2 | 0 | 0 | 7 | 7 |
| Uncharacterized serine/threonine-protein kinase SBK3 | 0 | 0 | 7 | 7 |
| Androgen receptor | 0 | 4 | 0 | 4 |
| Mast/stem cell growth factor receptor Kit | 0 | 5 | 8 | 13 |
| Insulin receptor-related protein | 0 | 0 | 7 | 7 |
| G2/mitotic-specific cyclin-B1 | 0 | 2 | 0 | 2 |
| Platelet-derived growth factor receptor alpha | 0 | 6 | 8 | 14 |
| Vascular endothelial growth factor receptor 1 | 0 | 4 | 7 | 11 |
| Interferon-induced, double-stranded RNA-activated protein kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase MAK | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 11B | 0 | 0 | 7 | 7 |
| Receptor tyrosine-protein kinase erbB-3 | 0 | 0 | 7 | 7 |
| Protein kinase C eta type | 0 | 2 | 7 | 9 |
| Activin receptor type-2A | 0 | 0 | 7 | 7 |
| Ephrin type-A receptor 8 | 0 | 0 | 7 | 7 |
| Leukocyte tyrosine kinase receptor | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase receptor UFO | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase 4 | 0 | 0 | 7 | 7 |
| G protein-coupled receptor kinase 4 | 0 | 0 | 7 | 7 |
| Prostaglandin G/H synthase 2 | 0 | 4 | 7 | 11 |
| Tyrosine-protein kinase receptor Tie-1 | 0 | 0 | 7 | 7 |
| Vascular endothelial growth factor receptor 3 | 0 | 3 | 7 | 10 |
| Vascular endothelial growth factor receptor 2 | 0 | 7 | 9 | 17 |
| Serine/threonine-protein kinase receptor R3 | 0 | 0 | 8 | 8 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit beta isoform | 0 | 3 | 7 | 10 |
| Megakaryocyte-associated tyrosine-protein kinase | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase TXK | 0 | 1 | 7 | 8 |
| Phosphatidylinositol 4,5-bisphosphate 3-kinase catalytic subunit gamma isoform | 0 | 3 | 7 | 10 |
| Cyclin-dependent kinase 8 | 0 | 1 | 7 | 8 |
| Choline-phosphate cytidylyltransferase A | 0 | 0 | 3 | 3 |
| Dual specificity protein kinase CLK3 | 0 | 0 | 8 | 8 |
| Tyrosine-protein kinase Blk | 0 | 1 | 7 | 8 |
| Cytoplasmic tyrosine-protein kinase BMX | 0 | 1 | 7 | 8 |
| cAMP-dependent protein kinase catalytic subunit PRKX | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek4 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase JAK3 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase PLK1 | 0 | 1 | 8 | 9 |
| Death-associated protein kinase 1 | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase 12 | 0 | 2 | 8 | 10 |
| 5'-AMP-activated protein kinase catalytic subunit alpha-2 | 0 | 0 | 7 | 8 |
| Ephrin type-B receptor 1 | 0 | 0 | 7 | 7 |
| Hormonally up-regulated neu tumor-associated kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase SIK1 | 0 | 2 | 7 | 9 |
| Receptor-interacting serine/threonine-protein kinase 4 | 0 | 0 | 7 | 7 |
| Cell division control protein 2 homolog | 0 | 0 | 7 | 7 |
| Calcium-dependent protein kinase 1 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 5-phosphate 4-kinase type-2 beta | 0 | 0 | 7 | 7 |
| SRSF protein kinase 2 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 9 | 0 | 0 | 7 | 7 |
| ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase PknB | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase-like 1 | 0 | 0 | 7 | 7 |
| Protein kinase C epsilon type | 0 | 2 | 7 | 9 |
| Angiopoietin-1 receptor | 0 | 3 | 7 | 10 |
| Mitogen-activated protein kinase kinase kinase 10 | 0 | 0 | 7 | 7 |
| Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase receptor TYRO3 | 0 | 1 | 7 | 8 |
| Cyclin-dependent kinase 18 | 0 | 0 | 8 | 8 |
| Tyrosine-protein kinase ITK/TSK | 0 | 1 | 7 | 8 |
| Myotonin-protein kinase | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase kinase kinase 12 | 0 | 0 | 7 | 7 |
| Tyrosine-protein kinase Mer | 0 | 2 | 8 | 10 |
| Serine/threonine-protein kinase PAK 1 | 0 | 2 | 7 | 9 |
| cGMP-dependent protein kinase 2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PRP4 homolog | 0 | 0 | 7 | 7 |
| Receptor-interacting serine/threonine-protein kinase 1 | 0 | 2 | 7 | 9 |
| Calcium/calmodulin-dependent protein kinase type II subunit beta | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1 | 0 | 0 | 7 | 7 |
| Lysine--tRNA ligase | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 10 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase D1 | 0 | 3 | 7 | 10 |
| Serine/threonine-protein kinase 38 | 0 | 0 | 7 | 7 |
| Receptor tyrosine-protein kinase erbB-4 | 0 | 0 | 7 | 7 |
| Ribosomal protein S6 kinase alpha-2 | 0 | 0 | 7 | 7 |
| Rhodopsin kinase GRK1 | 0 | 0 | 7 | 7 |
| NT-3 growth factor receptor | 0 | 0 | 7 | 7 |
| BDNF/NT-3 growth factors receptor | 0 | 1 | 7 | 8 |
| Mitogen-activated protein kinase 6 | 0 | 0 | 7 | 7 |
| Phosphorylase b kinase gamma catalytic chain, skeletal muscle/heart isoform | 0 | 0 | 7 | 7 |
| Uncharacterized aarF domain-containing protein kinase 5 | 0 | 0 | 3 | 3 |
| Serine/threonine-protein kinase SBK1 | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 19 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase TNNI3K | 0 | 1 | 7 | 8 |
| Leucine-rich repeat serine/threonine-protein kinase 2 | 0 | 0 | 7 | 7 |
| Sigma intracellular receptor 2 | 0 | 1 | 0 | 1 |
| Macrophage-stimulating protein receptor | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek5 | 0 | 0 | 7 | 7 |
| Dual serine/threonine and tyrosine protein kinase | 0 | 0 | 7 | 7 |
| Mitogen-activated protein kinase kinase kinase 15 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase tousled-like 2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 32C | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase pim-3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase VRK2 | 0 | 0 | 7 | 7 |
| Myosin light chain kinase family member 4 | 0 | 0 | 7 | 7 |
| Homeodomain-interacting protein kinase 1 | 0 | 1 | 7 | 8 |
| Calcium/calmodulin-dependent protein kinase type 1D | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase-like 3 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase BRSK2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase NIM1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase ULK2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase DCLK2 | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase kinase 1 | 0 | 0 | 7 | 7 |
| Casein kinase I isoform alpha-like | 0 | 0 | 7 | 7 |
| Mixed lineage kinase domain-like protein | 0 | 0 | 1 | 1 |
| Homeodomain-interacting protein kinase 4 | 0 | 1 | 7 | 8 |
| Myosin-IIIa | 0 | 0 | 7 | 7 |
| Ankyrin repeat and protein kinase domain-containing protein 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Nek11 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase BRSK1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 35 | 0 | 0 | 7 | 7 |
| Rhodopsin kinase GRK7 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 32A | 0 | 0 | 7 | 7 |
| Myosin-IIIb | 0 | 0 | 7 | 7 |
| Dual specificity tyrosine-phosphorylation-regulated kinase 2 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase-like 2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase Sgk3 | 0 | 0 | 7 | 7 |
| Atypical kinase COQ8B, mitochondrial | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type 1G | 0 | 0 | 8 | 8 |
| Cyclin-dependent kinase 15 | 0 | 0 | 7 | 7 |
| SRSF protein kinase 1 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-phosphate 5-kinase type-1 alpha | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase RIO1 | 0 | 0 | 7 | 7 |
| MAP kinase-interacting serine/threonine-protein kinase 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase RIO2 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 19 | 0 | 1 | 7 | 8 |
| Transient receptor potential cation channel subfamily M member 6 | 0 | 0 | 7 | 7 |
| Testis-specific serine/threonine-protein kinase 1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 33 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase DCLK3 | 0 | 0 | 7 | 7 |
| Myosin light chain kinase 2, skeletal/cardiac muscle | 0 | 0 | 7 | 7 |
| Homeodomain-interacting protein kinase 2 | 0 | 1 | 7 | 8 |
| Tyrosine-protein kinase Srms | 0 | 0 | 7 | 7 |
| Homeodomain-interacting protein kinase 3 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase PLK3 | 0 | 1 | 7 | 8 |
| MAP kinase-interacting serine/threonine-protein kinase 2 | 0 | 1 | 7 | 8 |
| Echinoderm microtubule-associated protein-like 4 | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase Nek6 | 0 | 0 | 7 | 7 |
| SNF-related serine/threonine-protein kinase | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase LATS2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 36 | 0 | 1 | 7 | 8 |
| Aurora kinase A-interacting protein | 0 | 1 | 0 | 1 |
| Serine/threonine-protein kinase 32B | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PLK2 | 0 | 1 | 7 | 8 |
| Serine/threonine-protein kinase MARK1 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase PAK 5 | 0 | 0 | 7 | 7 |
| eIF-2-alpha kinase GCN2 | 0 | 0 | 7 | 7 |
| Phosphatidylinositol 4-kinase beta | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase 17A | 0 | 0 | 7 | 7 |
| STE20/SPS1-related proline-alanine-rich protein kinase | 0 | 0 | 7 | 7 |
| Ephrin type-A receptor 6 | 0 | 0 | 7 | 7 |
| Death-associated protein kinase 2 | 0 | 0 | 7 | 7 |
| Serine/threonine-protein kinase tousled-like 1 | 0 | 0 | 7 | 7 |
| Long-chain-fatty-acid--CoA ligase 5 | 0 | 0 | 4 | 4 |
| ALK tyrosine kinase receptor | 0 | 3 | 8 | 11 |
| SRSF protein kinase 3 | 0 | 0 | 7 | 7 |
| Cyclin-dependent kinase 11A | 0 | 0 | 7 | 7 |
| Aurora kinase C | 0 | 0 | 7 | 7 |
| Calcium/calmodulin-dependent protein kinase type II subunit alpha | 0 | 0 | 7 | 7 |
| Microtubule-associated serine/threonine-protein kinase 1 | 0 | 0 | 7 | 7 |
| Chain A, Breast cancer type 1 susceptibility protein | 2 | 0 | 0 | 2 |
| alkaline phosphatase, intestinal | 0 | 1 | 1 | 2 |
| PINK1 | 1 | 0 | 0 | 1 |
| toll-like receptor 9 | 0 | 1 | 0 | 1 |
| TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
| alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 1 | 2 |
| polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
| perilipin-5 | 0 | 1 | 0 | 1 |
| intestinal alkaline phosphatase precursor | 0 | 1 | 1 | 2 |
| perilipin-1 | 0 | 1 | 0 | 1 |
| potassium voltage-gated channel subfamily H member 2 isoform d | 6 | 0 | 0 | 6 |
| transcriptional regulator ERG isoform 3 | 3 | 0 | 0 | 3 |
| importin subunit beta-1 isoform 1 | 1 | 0 | 0 | 1 |
| pyruvate kinase PKM isoform a | 1 | 0 | 0 | 1 |
| snurportin-1 | 1 | 0 | 0 | 1 |
| tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
| GTP-binding nuclear protein Ran isoform 1 | 1 | 0 | 0 | 1 |
| 1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
| alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 1 | 2 |
| hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
| DNA dC->dU-editing enzyme APOBEC-3F isoform a | 2 | 0 | 0 | 2 |
| Prostaglandin E synthase | 0 | 1 | 0 | 1 |
| D-amino-acid oxidase | 0 | 1 | 0 | 1 |
| Phospholipase A2 | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 4 | 1 | 5 |
| Amyloid-beta precursor protein | 1 | 3 | 1 | 6 |
| Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 2 | 1 | 3 |
| Heme oxygenase 1 | 0 | 1 | 0 | 1 |
| Glutathione S-transferase P | 0 | 1 | 0 | 1 |
| Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 4 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| Replicase polyprotein 1ab | 0 | 1 | 4 | 5 |
| Replicase polyprotein 1ab | 0 | 1 | 4 | 5 |
| Microtubule-associated protein tau | 0 | 1 | 0 | 2 |
| 60 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
| Tissue factor | 0 | 5 | 0 | 5 |
| Tyrosinase | 0 | 2 | 0 | 2 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Aminopeptidase N | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
| Glycogen synthase kinase-3 beta | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] A | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Heme oxygenase 2 | 0 | 1 | 0 | 1 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Amine oxidase [flavin-containing] B | 0 | 3 | 0 | 3 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| 17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
| Alpha-1A adrenergic receptor | 0 | 5 | 0 | 5 |
| Caspase-7 | 2 | 0 | 0 | 2 |
| Beta-secretase 1 | 0 | 1 | 0 | 1 |
| 10 kDa heat shock protein, mitochondrial | 0 | 2 | 0 | 2 |
| Guanine nucleotide-binding protein G | 2 | 0 | 0 | 2 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Lactoylglutathione lyase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 0 | 1 | 1 |
| Sodium/bile acid cotransporter | 0 | 0 | 1 | 1 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 1 | 4 | 7 |
| Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| 60 kDa chaperonin | 0 | 2 | 0 | 2 |
| 10 kDa chaperonin | 0 | 2 | 0 | 2 |
| Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
| Sortase A | 0 | 1 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
| Cysteine protease | 0 | 1 | 0 | 1 |
| NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
| Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
| Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
| P53 | 2 | 0 | 0 | 2 |
| Spike glycoprotein | 0 | 0 | 3 | 3 |
| Replicase polyprotein 1ab | 0 | 0 | 3 | 3 |
| heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 2 |
| transactivating tegument protein VP16 [Human herpesvirus 1] | 0 | 3 | 0 | 3 |
| COUP transcription factor 2 isoform a | 0 | 1 | 0 | 1 |
| Transmembrane protease serine 2 | 0 | 0 | 3 | 3 |
| Glucose transporter | 0 | 1 | 0 | 1 |
| Hexose transporter 1 | 0 | 1 | 0 | 1 |
| Procathepsin L | 0 | 0 | 3 | 3 |
| Replicase polyprotein 1a | 0 | 0 | 3 | 3 |
| Replicase polyprotein 1ab | 0 | 0 | 3 | 3 |
| Solute carrier family 2, facilitated glucose transporter member 1 | 0 | 1 | 0 | 1 |
| Eukaryotic initiation factor 4A-I | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 4 | 1 | 5 |
| Peptidyl-prolyl cis-trans isomerase FKBP3 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP4 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 0 | 3 | 1 | 4 |
| Hypoxia-inducible factor 1-alpha | 0 | 2 | 1 | 3 |
| Endothelial PAS domain-containing protein 1 | 0 | 1 | 1 | 2 |
| Angiotensin-converting enzyme 2 | 0 | 0 | 3 | 3 |
| Peptidyl-prolyl cis-trans isomerase FKBP14 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase NIMA-interacting 4 | 0 | 1 | 0 | 1 |
| heat shock protein 90, putative | 0 | 0 | 0 | 2 |
| LMP1 [Human herpesvirus 4] | 0 | 0 | 0 | 3 |
| nuclear receptor coactivator 1 isoform 1 [Homo sapiens] | 0 | 2 | 0 | 2 |
| nuclear receptor coactivator 3 isoform a | 0 | 2 | 0 | 2 |
| Thymidine kinase 2, mitochondrial | 0 | 1 | 0 | 1 |
| Thymidine kinase, cytosolic | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Thymidylate synthase | 0 | 0 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Probable deoxycytidylate deaminase | 0 | 0 | 0 | 1 |
| Cytidine deaminase | 0 | 1 | 0 | 2 |
| Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 1 | 0 | 1 |
| Thymidine kinase | 0 | 1 | 0 | 1 |
| Deoxynucleoside kinase | 0 | 1 | 0 | 1 |
| Isocitrate lyase | 0 | 1 | 0 | 1 |
| RAD51 | 0 | 1 | 0 | 1 |
| Dolichyl-diphosphooligosaccharide--protein glycosyltransferase subunit 1 | 0 | 1 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Pantothenate synthetase | 0 | 1 | 0 | 1 |
| Growth factor receptor-bound protein 2 | 0 | 1 | 0 | 1 |
| Reverse transcriptase/RNaseH | 0 | 2 | 0 | 2 |
| Peptide-N(4)-(N-acetyl-beta-glucosaminyl)asparagine amidase | 0 | 0 | 1 | 1 |
| Prothrombin | 0 | 1 | 0 | 1 |
| Glandular kallikrein | 0 | 1 | 0 | 1 |
| Cell division protein FtsZ | 0 | 0 | 1 | 2 |
| GALC protein | 4 | 0 | 0 | 4 |
| Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 1 | 0 | 1 |
| Transthyretin | 0 | 1 | 2 | 3 |
| Quinolone resistance protein NorA | 0 | 1 | 0 | 1 |
| Cytochrome P450 2A6 | 0 | 2 | 0 | 2 |
| Myosin light chain kinase, smooth muscle | 0 | 0 | 6 | 6 |
| Angiotensin-converting enzyme | 0 | 1 | 0 | 1 |
| Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
| Tyrosine-protein kinase Blk | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B6 | 0 | 3 | 0 | 3 |
| Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
| Tubulin alpha-1A chain | 0 | 0 | 6 | 6 |
| DNA-dependent protein kinase catalytic subunit | 0 | 3 | 0 | 3 |
| Myelin transcription factor 1 | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
| Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 1 | 0 | 1 |
| Sodium channel protein type 5 subunit alpha | 0 | 1 | 0 | 1 |
| Breakpoint cluster region protein | 0 | 1 | 0 | 1 |
| Eukaryotic peptide chain release factor GTP-binding subunit ERF3B | 0 | 0 | 1 | 1 |
| Protein cereblon | 0 | 2 | 1 | 4 |
| Potassium voltage-gated channel subfamily D member 3 | 0 | 1 | 0 | 1 |
| NF-kappa-B essential modulator | 0 | 1 | 0 | 1 |
| runt-related transcription factor 1 isoform AML1b | 1 | 0 | 0 | 1 |
| core-binding factor subunit beta isoform 2 | 1 | 0 | 0 | 1 |
| NADH-ubiquinone oxidoreductase chain 4 | 0 | 0 | 0 | 1 |
| 72 kDa type IV collagenase | 0 | 2 | 0 | 2 |
| Carbonyl reductase [NADPH] 1 | 0 | 0 | 0 | 1 |
| Glutamate receptor 1 | 2 | 0 | 0 | 2 |
| Glutamate receptor 3 | 2 | 0 | 0 | 2 |
| Glutamate receptor 4 | 2 | 0 | 0 | 2 |
| Platelet-activating factor receptor | 1 | 0 | 0 | 1 |
| Multidrug resistance-associated protein 1 | 0 | 2 | 0 | 3 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 1, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 2, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 3, mitochondrial | 0 | 1 | 0 | 1 |
| [Pyruvate dehydrogenase (acetyl-transferring)] kinase isozyme 4, mitochondrial | 0 | 1 | 0 | 1 |
| Cereblon isoform 4 | 0 | 2 | 0 | 2 |
| Insulin-like growth factor-binding protein 5 | 0 | 0 | 1 | 1 |
| Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 2 | 0 | 2 |
| Leukotriene A-4 hydrolase | 0 | 4 | 0 | 4 |
| Histone deacetylase-like amidohydrolase | 0 | 4 | 0 | 4 |
| NAD-dependent protein deacetylase sirtuin-1 | 0 | 2 | 1 | 5 |
| Histone deacetylase | 0 | 2 | 0 | 2 |
| Nuclear receptor corepressor 2 | 0 | 5 | 0 | 5 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 2B7 | 0 | 1 | 0 | 3 |
| acid sphingomyelinase | 2 | 0 | 0 | 2 |
| Type IV secretion-like conjugative transfer relaxase protein TraI | 0 | 1 | 0 | 1 |
| Regulatory protein E2 | 0 | 0 | 1 | 1 |
| DNA topoisomerase 2 | 0 | 0 | 0 | 1 |
| UDP-glucuronosyltransferase 1A1 | 0 | 0 | 0 | 1 |
| Serum paraoxonase/arylesterase 1 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 1 | 0 | 0 | 0 | 1 |
| Caspase-3 | 0 | 1 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2A | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2B | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2C | 0 | 0 | 0 | 1 |
| DNA topoisomerase 2-alpha | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 2D | 0 | 0 | 0 | 1 |
| Glutamate receptor ionotropic, NMDA 3B | 0 | 0 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
| Glutamate receptor ionotropic, NMDA 3A | 0 | 0 | 0 | 1 |
| Zinc finger protein GLI1 | 0 | 1 | 0 | 1 |
| Zinc finger protein GLI1 | 0 | 1 | 0 | 1 |
| Zinc finger protein GLI2 | 0 | 1 | 0 | 1 |
| Sonic hedgehog protein | 0 | 1 | 0 | 1 |
| Chain E, Fibrin beta chain | 0 | 1 | 0 | 1 |
| Chain A, RNA-directed RNA polymerase NS5 | 0 | 1 | 0 | 1 |
| WRN | 1 | 0 | 0 | 1 |
| Mcl-1 | 0 | 1 | 0 | 1 |
| MPI protein | 0 | 1 | 0 | 1 |
| Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
| hypothetical protein, conserved | 1 | 0 | 0 | 1 |
| luciferase | 2 | 0 | 0 | 2 |
| pyruvate kinase | 2 | 0 | 0 | 2 |
| glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 1 | 0 | 1 |
| CDK5 | 0 | 0 | 0 | 1 |
| serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
| major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
| glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 1 | 0 | 1 |
| serine/threonine-protein kinase PLK1 | 2 | 0 | 0 | 2 |
| Vif | 0 | 2 | 0 | 2 |
| Tat | 0 | 1 | 0 | 1 |
| endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
| Rap guanine nucleotide exchange factor 3 | 1 | 0 | 0 | 1 |
| Pyruvate kinase PKM | 0 | 1 | 1 | 2 |
| Endothelin receptor type B | 2 | 0 | 0 | 2 |
| Endothelin-1 receptor | 2 | 0 | 0 | 2 |
| hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
| H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
| large T antigen | 0 | 2 | 0 | 2 |
| Thioredoxin reductase 1, cytoplasmic | 0 | 1 | 0 | 1 |
| Dopamine beta-hydroxylase | 0 | 1 | 0 | 1 |
| Corticotropin-releasing factor receptor 1 | 0 | 1 | 0 | 1 |
| D(3) dopamine receptor | 0 | 3 | 0 | 3 |
| Cystathionine beta-synthase | 0 | 1 | 0 | 1 |
| Glutathione reductase | 0 | 1 | 0 | 1 |
| 5-lipoxygenase | 0 | 1 | 0 | 1 |
| Cysteine protease ATG4B | 0 | 1 | 0 | 1 |
| Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
| DNA polymerase III, partial | 3 | 0 | 0 | 3 |
| NPYLR7B | 0 | 0 | 2 | 2 |
| hexokinase-4 isoform 1 | 2 | 0 | 0 | 2 |
| D(1A) dopamine receptor | 3 | 0 | 0 | 3 |
| glucokinase regulatory protein | 2 | 0 | 0 | 2 |
| ubiquitin carboxyl-terminal hydrolase 2 isoform a | 2 | 0 | 0 | 2 |
| eyes absent homolog 2 isoform a | 1 | 0 | 0 | 1 |
| DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 1 |
| Cytochrome P450 2C8 | 0 | 0 | 0 | 1 |
| Cytochrome P450 3A5 | 0 | 1 | 0 | 2 |
| Chain A, Cell Division Protein Kinase 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, Cell Division Protein Kinase 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, CELL DIVISION PROTEIN KINASE 2 | 0 | 1 | 0 | 1 |
| Chain A, Cell Division Protein Kinase 2 | 0 | 1 | 0 | 1 |
| DNA repair and recombination protein RadA | 0 | 0 | 1 | 1 |
| Heat shock protein HSP 90-alpha | 0 | 0 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 0 | 1 | 1 |
| Nitric oxide synthase, brain | 0 | 1 | 0 | 1 |
| Chain A, Acetylcholinesterase | 0 | 1 | 0 | 1 |
| interferon gamma precursor | 0 | 0 | 0 | 2 |
| Solute carrier family 22 member 2 | 0 | 2 | 0 | 2 |
| Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
| Interstitial collagenase | 0 | 1 | 0 | 1 |
| Acetylcholinesterase | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
| Alpha-2C adrenergic receptor | 0 | 2 | 0 | 2 |
| Liver carboxylesterase 1 | 0 | 1 | 0 | 2 |
| Multidrug and toxin extrusion protein 2 | 0 | 2 | 0 | 2 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Chain A, Ribulose-1,5 bisphosphate carboxylase/oxygenase large subunit N-methyltransferase, chloroplast | 0 | 1 | 0 | 1 |
| Glutathione reductase, mitochondrial | 0 | 2 | 0 | 2 |
| Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
| Alpha-mannosidase 2C1 | 0 | 1 | 0 | 1 |
| Fucose-binding lectin PA-IIL | 0 | 1 | 0 | 1 |
| CD209 antigen | 0 | 1 | 0 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Methionyl-tRNA synthetase | 0 | 0 | 1 | 1 |
| Chain A, Aminopeptidase | 0 | 1 | 0 | 1 |
| Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
| S-ribosylhomocysteine lyase | 0 | 1 | 0 | 1 |
| Adenylate cyclase type 5 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-1 | 0 | 0 | 0 | 1 |
| S-adenosylmethionine synthase isoform type-2 | 0 | 0 | 0 | 1 |
| Fatty acid synthase | 0 | 1 | 0 | 1 |
| Large neutral amino acids transporter small subunit 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
| Glucocorticoid receptor | 0 | 4 | 1 | 10 |
| Glycine receptor subunit alpha-1 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit beta | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-2 | 0 | 4 | 0 | 4 |
| Glycine receptor subunit alpha-3 | 0 | 4 | 0 | 4 |
| Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 1 | 1 |
| Protein delta homolog 1 | 0 | 0 | 2 | 2 |
| Poly [ADP-ribose] polymerase tankyrase-2 | 0 | 1 | 2 | 3 |
| Nuclear receptor corepressor 1 | 0 | 1 | 0 | 1 |
| Integrin alpha-4 | 0 | 1 | 0 | 1 |
| Chain A, NAD-dependent deacetylase | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 0 | 1 |
| NAD-dependent histone deacetylase SIR2 | 0 | 1 | 0 | 1 |
| Coagulation factor VII | 0 | 2 | 0 | 2 |
| Poly [ADP-ribose] polymerase 1 | 0 | 3 | 2 | 5 |
| NAD-dependent protein deacetylase HST2 | 0 | 1 | 0 | 1 |
| Fatty-acid amide hydrolase 1 | 0 | 2 | 0 | 2 |
| Protein mono-ADP-ribosyltransferase PARP15 | 0 | 2 | 0 | 2 |
| NAD(+) hydrolase SARM1 | 0 | 1 | 0 | 1 |
| NAD-dependent protein deacetylase sirtuin-2 | 0 | 1 | 1 | 2 |
| NAD-dependent protein deacetylase sirtuin-6 | 0 | 2 | 1 | 3 |
| NAD-dependent protein deacetylase sirtuin-3, mitochondrial | 0 | 1 | 1 | 2 |
| NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 2 | 0 | 2 |
| NAD-dependent protein deacetylase | 0 | 1 | 0 | 1 |
| Protein Mdm4 | 0 | 2 | 0 | 2 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Delta-type opioid receptor | 0 | 1 | 2 | 3 |
| E3 ubiquitin-protein ligase Mdm2 | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase D | 0 | 1 | 0 | 1 |
| Mu-type opioid receptor | 0 | 0 | 1 | 1 |
| Poly [ADP-ribose] polymerase tankyrase-1 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP6 | 0 | 1 | 0 | 1 |
| Protein mono-ADP-ribosyltransferase PARP10 | 0 | 1 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP8 | 0 | 0 | 1 | 1 |
| Protein mono-ADP-ribosyltransferase PARP16 | 0 | 1 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP12 | 0 | 1 | 0 | 1 |
| Histamine H3 receptor | 0 | 1 | 0 | 1 |
| Poly [ADP-ribose] polymerase 2 | 0 | 1 | 2 | 3 |
| Protein mono-ADP-ribosyltransferase PARP4 | 0 | 1 | 1 | 2 |
| Protein mono-ADP-ribosyltransferase PARP3 | 0 | 1 | 2 | 3 |
| Genome polyprotein | 0 | 1 | 0 | 1 |
| Receptor protein-tyrosine kinase | 0 | 1 | 0 | 1 |
| Chain A, Protein (fibroblast Growth Factor (fgf) Receptor 1) | 0 | 1 | 0 | 1 |
| Platelet-derived growth factor receptor beta | 0 | 2 | 0 | 2 |
| Platelet-derived growth factor receptor alpha | 0 | 1 | 0 | 1 |
| Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
| Serine-protein kinase ATM | 0 | 1 | 0 | 1 |
| beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
| mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
| Vpr | 1 | 0 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
| Neuronal acetylcholine receptor subunit alpha-4 | 1 | 2 | 0 | 3 |
| Neuronal acetylcholine receptor subunit beta-2 | 1 | 2 | 0 | 3 |
| Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F | 0 | 1 | 0 | 1 |
| Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F | 0 | 1 | 0 | 1 |
| Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F | 0 | 1 | 0 | 1 |
| Chain A, PHOSPHOTIDYLINOSITOL 3 KINASE 59F | 0 | 1 | 0 | 1 |
| Phosphatidylinositol 4-phosphate 3-kinase C2 domain-containing subunit alpha | 0 | 1 | 0 | 1 |
| Disintegrin and metalloproteinase domain-containing protein 17 | 1 | 0 | 0 | 1 |
| C-X-C chemokine receptor type 4 | 0 | 1 | 0 | 1 |
| Atypical chemokine receptor 3 | 0 | 0 | 1 | 1 |
| C-C chemokine receptor type 2 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 4 | 0 | 2 | 0 | 4 |
| luciferase | 0 | 0 | 0 | 1 |
| Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
| Progesterone receptor | 0 | 3 | 0 | 4 |
| Glucocorticoid receptor | 0 | 1 | 1 | 2 |
| Glucocorticoid receptor | 0 | 0 | 1 | 1 |
| Corticosteroid-binding globulin | 0 | 1 | 0 | 1 |
| Mineralocorticoid receptor | 0 | 2 | 1 | 3 |
| Glutamine synthetase | 0 | 0 | 1 | 1 |
| Histamine H1 receptor | 0 | 0 | 1 | 1 |
| Nociceptin receptor | 0 | 0 | 1 | 1 |
| Cytochrome P450 2J2 | 0 | 1 | 0 | 1 |
| Chain A, Troponin C, slow skeletal and cardiac muscles | 0 | 0 | 1 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| Chain A, Leukotriene A-4 hydrolase | 0 | 1 | 0 | 1 |
| BRCA1 | 1 | 0 | 0 | 1 |
| ClpP | 1 | 0 | 0 | 1 |
| M18 aspartyl aminopeptidase | 0 | 1 | 0 | 1 |
| cathepsin L1 | 0 | 1 | 0 | 1 |
| histone deacetylase 9 isoform 3 | 2 | 0 | 0 | 2 |
| FAD-linked sulfhydryl oxidase ALR | 0 | 0 | 0 | 1 |
| transcription factor p65 isoform 1 | 0 | 0 | 1 | 1 |
| serine/threonine-protein kinase 33 isoform a | 0 | 0 | 1 | 1 |
| POsterior Segregation | 0 | 0 | 1 | 1 |
| Aryl hydrocarbon receptor | 0 | 1 | 0 | 1 |
| Estrogen receptor beta | 0 | 0 | 1 | 2 |
| Polyphenol oxidase 2 | 0 | 2 | 0 | 3 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 1 | 2 |
| Myc proto-oncogene protein | 0 | 1 | 0 | 2 |
| Cytochrome P450 1A1 | 0 | 1 | 0 | 1 |
| Cathepsin D | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
| Luciferin 4-monooxygenase | 0 | 1 | 0 | 1 |
| Tyrosinase | 0 | 4 | 0 | 4 |
| Ornithine decarboxylase | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 1A | 0 | 3 | 0 | 4 |
| Estrogen receptor | 0 | 0 | 1 | 2 |
| Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
| Sucrase-isomaltase, intestinal | 0 | 1 | 0 | 1 |
| Sodium-dependent noradrenaline transporter | 0 | 4 | 1 | 5 |
| Dipeptidyl peptidase 4 | 0 | 1 | 0 | 1 |
| ADP-ribosyl cyclase/cyclic ADP-ribose hydrolase 1 | 0 | 1 | 0 | 1 |
| Nitric oxide synthase, inducible | 0 | 2 | 0 | 2 |
| Cannabinoid receptor 1 | 0 | 1 | 0 | 1 |
| Alpha-glucosidase MAL12 | 0 | 1 | 0 | 1 |
| Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
| Squalene synthase | 0 | 1 | 0 | 1 |
| cAMP-specific 3',5'-cyclic phosphodiesterase 4B | 0 | 0 | 0 | 1 |
| N1L | 0 | 1 | 0 | 1 |
| NAD(P)H dehydrogenase [quinone] 1 | 0 | 0 | 0 | 4 |
| Lysosomal alpha-glucosidase | 0 | 1 | 0 | 1 |
| Transient receptor potential cation channel subfamily A member 1 | 0 | 1 | 0 | 1 |
| Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
| Prenyltransferase homolog | 0 | 0 | 0 | 1 |
| Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
| chaperonin-containing TCP-1 beta subunit homolog | 1 | 0 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-2 | 0 | 0 | 0 | 1 |
| Bile salt export pump | 0 | 2 | 0 | 2 |
| Albumin | 0 | 1 | 0 | 1 |
| Polymerase acidic protein | 0 | 0 | 1 | 1 |
| Stromelysin-1 | 0 | 0 | 1 | 1 |
| Tyrosine-protein phosphatase YopH | 0 | 1 | 0 | 1 |
| High mobility group protein B1 | 0 | 0 | 1 | 1 |
| Aldo-keto reductase family 1 member B1 | 0 | 1 | 0 | 1 |
| Cystathionine gamma-lyase | 0 | 1 | 0 | 1 |
| Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
| Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 20 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 8 | 0 | 1 | 0 | 1 |
| Solute carrier family 22 member 6 | 0 | 1 | 0 | 1 |
| Ubiquitin-like domain-containing CTD phosphatase 1 | 0 | 1 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit gamma-3 | 0 | 0 | 0 | 1 |
| 5'-AMP-activated protein kinase subunit beta-1 | 0 | 0 | 0 | 1 |
| Chain A, Erk2 | 0 | 1 | 0 | 1 |
| Mitogen-activated protein kinase 2 | 0 | 1 | 0 | 1 |
| cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Myeloperoxidase | 0 | 1 | 0 | 1 |
| Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
| Cholesteryl ester transfer protein | 0 | 1 | 0 | 1 |
| Amine oxidase [flavin-containing] B | 0 | 2 | 0 | 2 |
| Thromboxane-A synthase | 0 | 2 | 0 | 2 |
| Sodium-dependent serotonin transporter | 0 | 2 | 0 | 2 |
| Mitogen-activated protein kinase 14 | 0 | 1 | 1 | 2 |
| Mitogen-activated protein kinase 1 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 7 | 0 | 1 | 0 | 1 |
| P2X purinoceptor 7 | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter A | 0 | 1 | 0 | 1 |
| Neutral amino acid transporter B(0) | 0 | 1 | 0 | 1 |
| Proton-coupled amino acid transporter 1 | 0 | 1 | 0 | 1 |
| Amino acid transporter | 0 | 1 | 0 | 1 |
| Eukaryotic translation initiation factor 4E | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 1 | 0 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP1B | 0 | 0 | 1 | 1 |
| Peptidyl-prolyl cis-trans isomerase FKBP5 | 0 | 1 | 0 | 1 |
| Programmed cell death protein 4 | 0 | 0 | 1 | 1 |
| Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
| Solute carrier organic anion transporter family member 1B1 | 0 | 1 | 0 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, Mitogen-activated protein kinase 14 | 0 | 0 | 1 | 1 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | 0 | 1 | 0 | 1 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | 0 | 1 | 0 | 1 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | 0 | 1 | 0 | 1 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | 0 | 1 | 0 | 1 |
| Chain A, VASCULAR ENDOTHELIAL GROWTH FACTOR RECEPTOR 2 | 0 | 1 | 0 | 1 |
| melanocortin receptor 4 | 0 | 1 | 1 | 2 |
| 5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
| G1/S-specific cyclin-D1 | 0 | 1 | 0 | 1 |
| Cyclin-C | 0 | 1 | 1 | 2 |
| Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 2A | 0 | 3 | 0 | 3 |
| 5-hydroxytryptamine receptor 2C | 0 | 3 | 0 | 3 |
| Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 7 | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 3 | 0 | 1 | 0 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 5A | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 6 | 0 | 3 | 0 | 3 |
| MAP kinase-activated protein kinase 3 | 0 | 0 | 1 | 1 |
| Vascular endothelial growth factor receptor 2 | 0 | 1 | 0 | 1 |
| RuvB-like 2 | 0 | 1 | 1 | 2 |
| RuvB-like 1 | 0 | 1 | 0 | 1 |
| C-X-C chemokine receptor type 5 isoform 1 | 0 | 1 | 0 | 1 |
| C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
| apelin receptor | 0 | 1 | 0 | 1 |
| bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
| streptokinase A precursor | 0 | 0 | 2 | 2 |
| Endoglycoceramidase II | 0 | 0 | 0 | 1 |
| Protein kinase C alpha type | 0 | 2 | 0 | 2 |
| Estrogen receptor | 0 | 0 | 2 | 3 |
| Protein kinase C delta type | 0 | 2 | 0 | 2 |
| Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
| Protein kinase C zeta type | 0 | 2 | 0 | 2 |
| cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
| Protein kinase C gamma type | 0 | 2 | 0 | 2 |
| Protein kinase C beta type | 0 | 2 | 0 | 2 |
| Estrogen receptor beta | 0 | 0 | 2 | 3 |
| Protein kinase C eta type | 0 | 2 | 0 | 2 |
| Sphingosine kinase 2 | 0 | 1 | 0 | 1 |
| Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
| Protein kinase C theta type | 0 | 2 | 0 | 2 |
| Sphingosine 1-phosphate receptor 2 | 0 | 1 | 1 | 2 |
| Sphingosine 1-phosphate receptor 4 | 0 | 1 | 1 | 2 |
| Sphingosine 1-phosphate receptor 1 | 0 | 1 | 1 | 2 |
| Sodium-dependent serotonin transporter | 0 | 3 | 1 | 4 |
| Sphingosine 1-phosphate receptor 3 | 0 | 1 | 1 | 2 |
| Sphingosine 1-phosphate receptor 5 | 0 | 1 | 1 | 2 |
| Chain A, Ribosomal protein S6 kinase alpha-1 | 0 | 1 | 0 | 1 |
| Chain X, Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
| Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
| Chain A, Dual specificity protein kinase TTK | 0 | 0 | 1 | 1 |
| Transcription regulator protein BACH1 | 0 | 1 | 0 | 1 |
| Transcription factor MafK | 0 | 1 | 0 | 1 |
| Macrophage migration inhibitory factor | 0 | 1 | 0 | 1 |
| NAD | 0 | 0 | 0 | 1 |
| Delta-type opioid receptor | 0 | 0 | 0 | 1 |
| Quinone oxidoreductase | 0 | 0 | 0 | 3 |
| Kelch-like ECH-associated protein 1 | 0 | 1 | 2 | 3 |
| Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 0 | 1 |
| Kelch-like ECH-associated protein 1 | 0 | 0 | 0 | 1 |
| Chain A, CES1 protein | 0 | 1 | 0 | 1 |
| 5-hydroxytryptamine receptor 4 | 0 | 2 | 0 | 2 |
| Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
| Muscarinic acetylcholine receptor M2 | 0 | 2 | 0 | 2 |
| Beta-1 adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M5 | 0 | 2 | 0 | 2 |
| Alpha-2A adrenergic receptor | 0 | 2 | 0 | 2 |
| Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
| Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
| Angiotensin-converting enzyme | 0 | 2 | 0 | 2 |
| Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
| D(2) dopamine receptor | 0 | 2 | 0 | 2 |
| Alpha-2B adrenergic receptor | 0 | 2 | 0 | 2 |
| Muscarinic acetylcholine receptor M3 | 0 | 2 | 0 | 2 |
| Substance-K receptor | 0 | 2 | 0 | 2 |
| D(1A) dopamine receptor | 0 | 2 | 0 | 2 |
| D(4) dopamine receptor | 0 | 2 | 0 | 2 |
| UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 1 |
| Histamine H2 receptor | 0 | 2 | 0 | 2 |
| Alpha-1D adrenergic receptor | 0 | 2 | 0 | 2 |
| Substance-P receptor | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 1B | 0 | 2 | 0 | 2 |
| B2 bradykinin receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
| C-8 sterol isomerase | 0 | 1 | 0 | 1 |
| Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
| Mu-type opioid receptor | 0 | 2 | 0 | 2 |
| Delta-type opioid receptor | 0 | 3 | 0 | 3 |
| Kappa-type opioid receptor | 0 | 2 | 0 | 2 |
| Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
| Phospholipase D1 | 0 | 1 | 0 | 1 |
| Sodium-dependent dopamine transporter | 0 | 2 | 0 | 2 |
| Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
| Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
| 3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 2 | 1 | 3 |
| Nuclear receptor subfamily 3 group C member 3 | 0 | 2 | 0 | 2 |
| Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
| Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
| 7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
| polyadenylate-binding protein 1 | 0 | 1 | 0 | 1 |
| atrial natriuretic peptide receptor 1 precursor | 1 | 0 | 0 | 1 |
| Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 1 | 0 | 1 |
| Cytochrome P450 2B1 | 0 | 1 | 0 | 1 |
| Chain A, Nuclear Receptor ROR-beta | 0 | 1 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Ornithine decarboxylase | 0 | 0 | 0 | 1 |
| Retinoic acid receptor alpha | 0 | 2 | 2 | 7 |
| Retinoic acid receptor beta | 0 | 2 | 2 | 7 |
| Retinoic acid receptor alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor gamma | 0 | 2 | 2 | 7 |
| Alpha-1A adrenergic receptor | 0 | 1 | 0 | 1 |
| Retinoic acid receptor gamma | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-alpha | 0 | 2 | 2 | 4 |
| Retinoic acid receptor beta | 0 | 1 | 2 | 3 |
| Cellular retinoic acid-binding protein 2 | 0 | 0 | 1 | 1 |
| Retinoic acid receptor RXR-alpha | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-beta | 0 | 2 | 2 | 4 |
| Retinoic acid receptor RXR-beta | 0 | 1 | 2 | 3 |
| Retinoic acid receptor RXR-gamma | 0 | 1 | 2 | 3 |
| Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-alpha | 0 | 1 | 0 | 1 |
| Cellular retinoic acid-binding protein 1 | 0 | 1 | 0 | 2 |
| Retinoic acid receptor RXR-gamma | 0 | 2 | 2 | 4 |
| Cellular retinoic acid-binding protein 1 | 0 | 0 | 1 | 1 |
| Indoleamine 2,3-dioxygenase 2 | 0 | 1 | 0 | 1 |
| Nuclear receptor ROR-beta | 0 | 1 | 0 | 1 |
| Chain A, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | 0 | 1 | 0 | 1 |
| Chain B, HDLP (HISTONE DEACETYLASE-LIKE PROTEIN) | 0 | 1 | 0 | 1 |
| Chain A, Histone deacetylase 7a | 0 | 1 | 0 | 1 |
| Chain A, Histone deacetylase 7a | 0 | 1 | 0 | 1 |
| Histone deacetylase | 0 | 1 | 0 | 1 |
| Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
| unnamed protein product | 0 | 0 | 0 | 1 |
| Histone deacetylase 1 | 0 | 2 | 0 | 2 |
| 5-hydroxytryptamine receptor 3A | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Vitamin D3 receptor | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase 2 | 0 | 1 | 0 | 1 |
| Splicing factor 3B subunit 3 | 0 | 1 | 0 | 1 |
| Histone deacetylase 1 | 0 | 1 | 0 | 1 |
| Adenosine receptor A1 | 0 | 1 | 0 | 1 |
| Histone deacetylase | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Polyamine deacetylase HDAC10 | 0 | 1 | 0 | 1 |
| Histone deacetylase 3 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 8 | 0 | 1 | 0 | 1 |
| Histone deacetylase 11 | 0 | 1 | 0 | 1 |
| HD2 type histone deacetylase HDA106 | 0 | 2 | 0 | 2 |
| Histone deacetylase 9 | 0 | 1 | 0 | 1 |
| Histone deacetylase 7 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 4 | 0 | 1 | 0 | 1 |
| Histone deacetylase 6 | 0 | 1 | 0 | 1 |
| Histone deacetylase 5 | 0 | 1 | 0 | 1 |
| Histone deacetylase | 0 | 1 | 0 | 1 |
| Malate dehydrogenase | 0 | 1 | 0 | 1 |
| Cocaine esterase | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1A9 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
| Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
| Sigma non-opioid intracellular receptor 1 | 0 | 1 | 0 | 1 |
| Butyrophilin subfamily 3 member A1 | 0 | 0 | 1 | 2 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 3 |
| Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Neutrophil collagenase | 0 | 1 | 0 | 1 |
| Farnesyl diphosphate synthase | 0 | 1 | 0 | 1 |
| Matrix metalloproteinase-14 | 0 | 1 | 0 | 1 |
| Farnesyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Geranylgeranyl pyrophosphate synthase | 0 | 2 | 0 | 2 |
| Farnesyl pyrophosphate synthase | 0 | 1 | 0 | 1 |
| H | 0 | 1 | 0 | 1 |
| [prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |